You are here

  • Home
  • Archive
  • Volume 68, Issue 4
  • Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF
PostScript
Correspondence
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

https://doi.org/10.1136/jclinpath-2015-202866

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • We have no notifications for acknowledgement, collaborators, funding, disclaimer, patient consent, ethics approval and/or data sharing statements

    Linked Articles

    • Errata
      Correction
      BMJ Publishing Group Ltd and Association of Clinical Pathologists
      Journal of Clinical Pathology 2015; 68 e2-e2 Published Online First: 19 Jun 2015. doi: 10.1136/jclinpath-2015-202866corr1